August 2018

Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 125 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.

Phase 1 immunotherapy trials

Phase 1 studies are the springboard for advancing new cancer treatments. Providence Cancer Institute o ffers many phase 1 trials for multiple cancer types, including two new studies for people with head and neck cancer and melanoma: Pre-surgical anti-OX40 for melanoma or head and neck squamous cell carcinoma – a study offered only at Providence Cancer Institute INCAGN01876 in combination with immune therapies – currently open to patients with PD-1 or PD-L1 relapsed metastatic melanoma Read More About These Studies

All current open studies:

Brain Cancer Breast Cancer Gastrointestinal Cancers  Genitourinary Cancers Gynecologic Cancers

Head and Neck Cancers Hematologic Cancers Lung Cancer Melanoma Phase 1 Trials

Find additional studies for many types of cancer in Multiple Tumor Types .

New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.

Refer A Patient

Email Our Team

See All Open Studies

Earle A. Chiles Research Institute

Sign up to receive this newsletter

‌ ‌ ‌